Finding the rare mutant allele needle in the wild-type haystack

October 4, 2012 at 4:05 pm Leave a comment

Studies of biomarkers associated with the onset of and progression of cancers have been fraught with poor selectivity and have failed to detect mutant sequences with abundances of less than 1 in 100 wild-type sequences. The QX100 ddPCR platform offers a simple and robust means to increase the precision and sensitivity of TaqMan assays for rare event detections. Not only are direct counts of template molecules within a sample possible (Pinheiro et al. 2012), but partitioning mitigates the effects of target competition, greatly improving the discriminatory capacity of assays that differ by only a single nucleotide. Here, the benefits for clinically relevant assay targets are demonstrated through the BRAF V600E mutation assay, where the LOD improved >100-fold when performed in ddPCR. This platform should prove invaluable to the molecular diagnostics field in general and to the cancer field in particular for the routine assessment of mutation status. Combined with the high accuracy achieved through the use of tens of thousands of partitions, ddPCR represents a unique platform for extremely precise and sensitive measurements of target molecules.

Click here to learn more on how Bio-Rad Laboratories’ QX100™ Droplet Digital™ PCR System can aid in the detection of rare mutant alleles within a background of wild-type sequences.

Entry filed under: Bio-Rad Tech Note, Droplet Digital PCR. Tags: , , .

Do Proteins Have Their Own Social Network? Health check finds Canadian science doing well

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


biorad1

Bio-Rad Canada has sponsored the development of this site to advance the productivity of the Canadian Biotechnology sector and the fine people who work in it across the country.  We invite readers to contribute content: posters, tools, research and presentations, articles white papers, multimedia, music downloads and entertainment, conference announcements, videos. Please contact info@cbt20.ca for more information.

Bookmark and Share

Site developed by What If What Next(TM)

Follow us on Twitter


%d bloggers like this: